Ann Arbor, MI 的 多發性骨髓瘤 臨床試驗
10 項針對 多發性骨髓瘤 的研究正在 Ann Arbor（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
招募中2 期
- University of Michigan Health System, Ann Arbor
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
招募中3 期
- University of Michigan, Ann Arbor
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
招募中2 期
- Trinity Health Ann Arbor Hospital, Ann Arbor
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
招募中1/2 期
- University of Michigan Health System - Ann Arbor /ID# 271536, Ann Arbor
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
招募中1/2 期
- Research Site, Ann Arbor
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
招募中3 期
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 距離 7 英里
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 距離 7 英里
- 還有 4 項
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
招募中1/2 期
- Research Site, Ann Arbor
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
招募中4 期
- University of Michigan, Ann Arbor
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
招募中3 期
- Saint Joseph Mercy Hospital, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 距離 7 英里
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 距離 7 英里
- 還有 4 項
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
招募中3 期
- GSK Investigational Site, Ann Arbor
其他城市的 多發性骨髓瘤 試驗
- New York City, NY60 項研究
- Boston, MA42 項研究
- Atlanta, GA41 項研究
- Houston, TX38 項研究
- Durham, NC37 項研究
- Nashville, TN32 項研究
- Denver, CO27 項研究
- Rochester, MN24 項研究
- St. Louis, MO24 項研究
- Columbus, OH24 項研究
- Baldwin Park, CA23 項研究
- Chicago, IL22 項研究
Ann Arbor 的其他研究
- 前列腺癌27 項研究
- 乳癌26 項研究
- 非小細胞肺癌26 項研究
- 癌症（所有類型）25 項研究
- 大腸直腸癌23 項研究
- 肺癌23 項研究
- 心臟衰竭22 項研究
- 急性髓系白血病17 項研究
- 心血管疾病16 項研究
- 胰臟癌14 項研究
- 黑色素瘤12 項研究
- 腎臟癌（腎細胞癌）12 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。